Predicting DNA Damage | GenomeWeb

Predicting DNA Damage

Premium

Researchers led by Rebecca Fry at MIT, who is now at the University of North Carolina School of Public Health, have discovered a gene expression signature that can predict how well cells will respond to a DNA damaging agent. Extending this basic work to the clinic could mean better predicting how patients will respond to chemotherapy. The scientists published their findings in the September 19 online edition of the Journal Genes and Development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.